IL-15 synergizes with CD40 agonist antibodies to induce durable immunity against bladder cancer
IL-15 synergizes with CD40 agonist antibodies to induce durable immunity against bladder cancer
About this item
Full title
Author / Creator
Publisher
Cold Spring Harbor: Cold Spring Harbor Laboratory Press
Journal title
Language
English
Formats
Publication information
Publisher
Cold Spring Harbor: Cold Spring Harbor Laboratory Press
Subjects
More information
Scope and Contents
Contents
CD40 is a central co-stimulatory receptor implicated in the development of productive anti-tumor immune responses across multiple cancers, including bladder cancer. Despite strong preclinical rationale, systemic administration of therapeutic agonistic antibodies targeting the CD40 pathway have demonstrated dose limiting toxicities with minimal clin...
Alternative Titles
Full title
IL-15 synergizes with CD40 agonist antibodies to induce durable immunity against bladder cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2771484704
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2771484704
Other Identifiers
E-ISSN
2692-8205
DOI
10.1101/2023.01.30.526266
How to access this item
https://www.proquest.com/docview/2771484704?pq-origsite=primo&accountid=13902
